Functional study of residual T lymphocytes after specific elimination of alloreactive T cells by a specific anti-interleukin-2 receptor Bk chain immunotoxin.
Valteau-Couanet
D
D
INSERM U 132, Hôpital des Enfants-malades, Paris, France.
Cavazzana-Calvo
M
M
Le Deist
F
F
Fromont
C
C
Fischer
A
A
D000918:Antibody Specificity; D000946:Antigens, Fungal; D000956:Antigens, Viral; D016465:Bone Marrow Purging; D016026:Bone Marrow Transplantation / Q000009:adverse effects / Q000276:immunology; D002175:Candida / Q000276:immunology; D003587:Cytomegalovirus / Q000276:immunology; D006084:Graft Rejection / Q000517:prevention & control; D004854:Herpesvirus 4, Human / Q000276:immunology; D006801:Humans; D000922:Immunotoxins / Q000494:pharmacology; D008213:Lymphocyte Activation; D008212:Lymphocyte Depletion; D015375:Receptors, Interleukin-2 / Q000276:immunology*; D013601:T-Lymphocytes / Q000276:immunology*
D000946:Antigens, Fungal; D000956:Antigens, Viral; D000922:Immunotoxins; D015375:Receptors, Interleukin-2